Clinical Trial: Cell Therapy as Treatment for Cerebral Palsy
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Autologous Bone Marrow Mononuclear Cell Therapy in Cerebral Palsy
Brief Summary: The purpose of this study was to study the effect of autologous bone marrow mononuclear cells on common symptoms of cerebral palsy patients.
Detailed Summary:
Sponsor: Neurogen Brain and Spine Institute
Current Primary Outcome: change in clinical symptoms over a period of 2 years [ Time Frame: 2 years ]
Original Primary Outcome: change in clinical symptoms over a period of 2 years [ Time Frame: 2 years ]
Current Secondary Outcome:
- Change in GMFM score [ Time Frame: 1 year ]
- Change in Gross Motor Function Measure [ Time Frame: 1 year ]
Original Secondary Outcome: Same as current
Information By: Neurogen Brain and Spine Institute
Dates:
Date Received: September 12, 2014
Date Started: August 2013
Date Completion: June 2017
Last Updated: September 23, 2016
Last Verified: September 2016